Marc Gerdisch - Concepedia

Author

Marc Gerdisch

Also Known As

Arnar Geirsson, H Yerebakan, M Gerdisch, M. Gerdisch, M. W. Gerdisch, Marc Gerdisch, Marc W Gerdisch, Marc W. Gerdisch, Marc William Gerdisch

Publications

Citations

H-Index

Concepts

All Affiliations

Franciscan Health Indianapolis Duke University West Virginia University Allina Health Temple University

About

Marc Gerdisch is an author at Franciscan Health Indianapolis specializing in cardiology, medicine, and anesthesiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	14	1.2K
2	Public Health	7	8	690
3	Cardiothoracic Surgery	5	6	180
4	Emergency Medicine	4	4	740
5	Epidemiology	1	1	57

Marc Gerdisch

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial John D. Puskas, Marc Gerdisch, Dennis Nichols, Journal of Thoracic and Cardiovascular Surgery ThrombosisCardiovascular DiseasePatient SafetyInterim ResultsValvular Heart Disease	2014	280
Exclusion of the left atrial appendage with a novel device: Early results of a multicenter trial Gorav Ailawadi, Marc Gerdisch, Richard L. Harvey, Journal of Thoracic and Cardiovascular Surgery Heart FailureNovel DeviceDevice TherapyCardiac AnaesthesiaMulticenter Trial	2011	271
Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement John D. Puskas, Marc Gerdisch, Dennis Nichols, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseBlood PlateletPlatelet AntagonistValve Disease	2018	132
Randomized, multicenter trial comparing sternotomy closure with rigid plate fixation to wire cerclage Keith B. Allen, Vinod H. Thourani, Yoshifumi Naka, Journal of Thoracic and Cardiovascular Surgery	2016	120
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve Tracy Y. Wang, Lars G. Svensson, Jun Wen, NEJM Evidence Vitamin K AntagonistsThrombosisCardiovascular DiseaseApixaban Event RateCardiovascular Pharmacology	2023	108
Minimally invasive surgical ablation of atrial fibrillation: Six-month results James R. Edgerton, James H. McClelland, David J. Duke, Journal of Thoracic and Cardiovascular Surgery Minimally Invasive ProcedureSurgeryAtrial FibrillationMedicineCardiology	2009	90
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve Oliver K. Jawitz, Tracy Y. Wang, Renato D. Lópes, American Heart Journal Proact XaCardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionThrombosis	2020	81
Clinical experience with CorMatrix extracellular matrix in the surgical treatment of mitral valve disease Marc Gerdisch, Richard J. Shea, Michael D. Barron Journal of Thoracic and Cardiovascular Surgery	2013	78
Early experience treating tricuspid valve endocarditis with a novel extracellular matrix cylinder reconstruction Marc Gerdisch, W. Douglas Boyd, John L. Harlan, Journal of Thoracic and Cardiovascular Surgery	2014	59
Cardiac surgery in North America and coronavirus disease 2019 (COVID-19): Regional variability in burden and impact Niv Ad, Jessica G.Y. Luc, Tom C. Nguyen, Journal of Thoracic and Cardiovascular Surgery Cardiac SurgeryCardiovascular DiseaseMedicineGlobal HealthCovid-19 Pandemic	2020	57

Page 1